Pfizer and Astellas gain positive trial results for prostate cancer treatment

Pfizer and Astellas have announced results from the Phase III ARCHES trial in men with metastatic hormone-sensitive prostate cancer (HSPC), showing that Enzalutamide had significantly improved radiographic progression-free survival, paving the way for an application to expand the drug’s use. The results, which are for the drug in combination with androgen deprivation therapy, show a

Continue Reading

CCRA seminar: UK Clinical Research – A Professionals Awareness Update & The Landscape for CROs post Brexit

Clinical Professionals will be attending a vital two-day event hosted by the CCRA on the 29th-30th January at the Royal Society of medicine in London. In an unquestionable time of industrial and economic upheaval across all sectors, the event looks to bring together various key members from Government, the Department of Health, industry regulators and

Continue Reading

Yvette Cleland discusses Reskilling and Upskilling with RIX

Clinical Professionals CEO, Yvette Cleland, recently met with Recruitment Innovation Exchange (RIX) to discuss reskilling and upskilling as an essential factor in the pharmaceutical recruitment sector in 2019. The Recruitment Innovation and Exchange was created by Bullhorn as a way to initiate conversation and collaboration amongst global recruitment leaders and influencers. It features a purpose

Continue Reading